HCV Tumor Promoting Effect Is Dependent on Host Genetic Background

• Naama Klopstock,

  Affiliation Goldyne Savad Institute of Gene Therapy, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

  ⨯
• Mark Katzenellenbogen,

  Affiliation Bioinformatics and Microarray Unit, The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel

  ⨯
• Orit Pappo,

  Affiliation Department of Pathology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

  ⨯
• Miriam Sklair-Levy,

  Affiliation Breast Imaging Center, Sheba Medical Center, Tel Hashomer, Israel

  ⨯
• Devorah Olam,

  Affiliation Goldyne Savad Institute of Gene Therapy, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

  ⨯
• Lina Mizrahi,

  Affiliation Goldyne Savad Institute of Gene Therapy, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

  ⨯
• Tamara Potikha,

  Affiliation Goldyne Savad Institute of Gene Therapy, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

  ⨯
• Eithan Galun,

  Affiliation Goldyne Savad Institute of Gene Therapy, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

  ⨯
• Daniel Goldenberg

  * E-mail: goldenberg@hadassah.org.il

  Affiliation Goldyne Savad Institute of Gene Therapy, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

  ⨯